![]() | |
Clinical data | |
---|---|
Other names | TFMCPP; meta-Trifluoromethyl-para-chlorophenylpiperazine; PAL-179; PAL179 |
Drug class | Selective partial serotonin releasing agent |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C11H12ClF3N2 |
Molar mass | 264.68 g·mol−1 |
3D model (JSmol) | |
| |
|
3-Trifluoromethyl-4-chlorophenylpiperazine (TFMCPP; code name PAL-179), or meta-trifluoromethyl-para-chlorophenylpiperazine, is a monoamine releasing agent of the phenylpiperazine family. [1] It acts specifically as a selective partial serotonin releasing agent, with an EC50 of 33 nM and an Emax of 66%. [1] The drug was inactive as a releasing agent of dopamine or norepinephrine (EC50 >10,000 nM). [1] Its possible activity at serotonin receptors was not reported. [1] TFMCPP was first described in the scientific literature by 2012. [1]